Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |